Page last updated: 2024-08-21

quinazolines and Fra(X) Syndrome

quinazolines has been researched along with Fra(X) Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barmada, SJ; Flores, BN; Green, KM; Ivanova, MI; Kearse, MG; Sheth, UJ; Sutter, AB; Todd, PK; Wright, SE1
Heldermon, CD; Kitada, K; Koyama, M; Meacham, AM; Pacak, CA; Santostefano, KE; Tachibana, D; Terada, N; Waldrop, SM; Watanabe, N; Yokoyama, A1

Other Studies

2 other study(ies) available for quinazolines and Fra(X) Syndrome

ArticleYear
High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation.
    The Journal of biological chemistry, 2019, 12-06, Volume: 294, Issue:49

    Topics: Amyotrophic Lateral Sclerosis; Animals; Ataxia; Azepines; Cells, Cultured; Circular Dichroism; DNA Repeat Expansion; Drug Evaluation, Preclinical; Fragile X Syndrome; HEK293 Cells; Humans; Neurodegenerative Diseases; Propidium; Pyrimidines; Quinazolines; Rats; Tremor; Trinucleotide Repeat Expansion

2019
Generation of Induced Pluripotent Stem Cells from a Female Patient with a Xq27.3-q28 Deletion to Establish Disease Models and Identify Therapies.
    Cellular reprogramming, 2020, Volume: 22, Issue:4

    Topics: Cell Differentiation; Cells, Cultured; Child, Preschool; Chromosome Deletion; Chromosomes, Human, X; Decitabine; Developmental Disabilities; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Induced Pluripotent Stem Cells; Intellectual Disability; Quinazolines

2020